THE SHORT ANSWER
High-Performance Science Teams™ helps service CROs , study directors, project managers, laboratory teams, QA, report writing, and business development, operate as one team from quote to final report. It targets the behaviors that cost repeat business: timelines sold before operations validates them, late bad news, unmanaged scope change, and sponsors hearing different answers from different people.
Why do sponsors leave CROs whose science is good?
Sponsors rarely switch CROs because the data was wrong. They switch because the experience was: a study start that slipped after the contract was signed, a report that arrived three weeks late with no warning, a scope change that became a billing dispute, a study director who was the only person who knew what was happening.
Every one of those is a team failure dressed up as an individual one. In a services business, the sponsor experiences the seams between your functions as your brand.
What does team dysfunction look like inside a service CRO?
- BD sells a timeline operations didn’t validate. The quote goes out on a study-start date the lab schedule can’t support, and the study director inherits the credibility problem.
- The study director as single point of failure. Scientific, client, and operational decisions all route through one person, who becomes the bottleneck.
- Blurred study director and project manager roles. Sponsors don’t know who owns the timeline versus the science, and neither do the teams.
- Scope creep absorbed instead of managed. Added endpoints, extra timepoints, and protocol changes get done without change orders, margin leaks and resentment builds.
- Late bad news. A failed run, a QA audit finding, or an animal-availability issue waits until it can’t be hidden.
- Report turnaround drift. The handoff from in-life or bench teams to report writing and QA review has no shared deadline owner.
What does team science say about fixing it?
Two of the most cited findings on team effectiveness apply directly. Gallup’s research on managers found they account for at least 70% of the variance in team engagement across business units. And Google’s Project Aristotle found psychological safety whether team members feel safe to take risks and raise problems to be the most important factor distinguishing effective teams.
Neither was studied in CROs specifically. But both describe exactly the conditions under which bad news travels early and scope changes get raised instead of absorbed.
How does High-Performance Science Teams™ work for CRO teams?
The program applies Guttman Development Strategies’ horizontal high-performance team model to CRO site leadership and study teams, working on live sponsor programs.
| Client-risk pattern | Root behavior | What HPT installs |
| Timelines sold that ops can’t hit | BD and operations goals misaligned | A quote-to-study-start protocol with operations sign-off before commitment |
| Study director bottleneck | Hub-and-spoke decision-making | Explicit decision rights across study director, PM, and lab leads |
| Unmanaged scope change | Avoidance of difficult sponsor conversations | Shared norms and scripts for raising scope and change orders early |
| Late bad news | Low psychological safety | An early-warning protocol: raise risk within a set window, no blame |
| Report turnaround drift | No shared owner across handoffs | Peer accountability for report milestones across lab, writing, and QA |
How does this connect to the customer-facing side of the CRO?
High-Performance Science Teams™ aligns the team behind the study. Bench to Business™, our companion program, builds the customer-facing skills of study directors, scientific project managers, and BD scientists, discovery conversations, sponsor updates, and handling objections. CROs that run both close the gap between what is sold and what is delivered.
Who is it for?
Presidents and general managers, VPs of Operations, heads of study direction and project management, and BD leaders at discovery, safety assessment, DMPK, bioanalytical, and specialty service CROs — especially organizations growing site headcount or consolidating after acquisition.
How do we get started?
Start with the Science Team 360™, a short, confidential team-level diagnostic that shows exactly where decision rights, alignment, and accountability are breaking down inside your CRO site or study team. You get a readout before anyone commits to a full engagement.
Request a Science Team 360™ conversation at bench2business.bio.
Frequently asked questions
Why do sponsors switch CROs?
Sponsors commonly switch because of the service experience rather than the science: missed study-start dates, late or surprising updates, unmanaged scope changes, and inconsistent communication across the CRO team.
How can a CRO improve client retention?
By aligning BD, study direction, project management, lab operations, and QA on shared commitments to each sponsor, validating timelines before quoting, raising risks early, and managing scope changes openly.
What is the difference between a study director and a project manager in a CRO?
Roles vary, but typically the study director owns scientific conduct and GLP compliance of the study, while the project manager owns timeline, budget, and sponsor logistics. High-performing teams make these decision rights explicit.
Does High-Performance Science Teams™ replace project management tools or GLP processes?
No. It improves how the team works within them, how it decides, escalates, and holds itself accountable.
How do we start?
With the Science Team 360™, a confidential diagnostic that shows where your study teams’ alignment, decision rights, and accountability break down.
Sources
- Gallup, State of the American Manager: Analytics and Advice for Leaders (2015) — https://www.gallup.com/services/182138/state-american-manager.aspx
- Google re:Work, “Guide: Understand team effectiveness” (Project Aristotle) — https://rework.withgoogle.com/guides/understanding-team-effectiveness/
- Guttman, H.M. Great Business Teams: Cracking the Code for Standout Performance (Wiley, 2008) — https://www.guttmandev.com/great-business-teams
Figures from third-party studies are cited as published. Cross-industry data is presented as directional for life science. Program outcomes described are targets teams track against their own Science Team 360™ baseline, not guaranteed results.